• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

蛛网膜下腔出血后迟发性脑缺血的临床预测因素:在破裂脑动脉瘤的治疗中使用线圈栓塞的初步经验。

Clinical predictors of delayed cerebral ischemia after subarachnoid hemorrhage: first experience with coil embolization in the management of ruptured cerebral aneurysms.

机构信息

Department of Neurosurgery, Hamamatsu Rosai Hospital, Shizuoka, Japan.

出版信息

J Neurointerv Surg. 2011 Dec 1;3(4):344-7. doi: 10.1136/jnis.2010.004077. Epub 2011 Mar 1.

DOI:10.1136/jnis.2010.004077
PMID:21990439
Abstract

OBJECTIVE

The purpose of this study was to clarify the clinical predictors of delayed cerebral ischemia (DCI) after subarachnoid hemorrhage (SAH).

METHODS

102 patients with ruptured cerebral aneurysms were treated (77 by clipping and 25 by coiling). 40 patients were male and 62 were female. Median age was 59 years (range 31-88). The modified Rankin Scale was used to assess functional outcomes 3 months after treatment or at discharge. The associations between potential clinical risk factors and DCI after SAH were assessed using the χ(2) test.

RESULTS

52 patients (51.0%) had a good outcome and 13 patients (12.7%) died despite treatment. DCI was observed in 26 patients and hydrocephalus was observed in 37 patients. There were marginal differences in clinical outcomes between the treatment groups (p=0.053), mainly because functional outcomes were significantly superior in the coiling group (p=0.04) in patients with severe SAH. DCI was seen less frequently in the coiling group than in the clipping group (4.0% vs 32.4%, p=0.001). The presence of hydrocephalus was significantly associated with the occurrence of DCI (p<0.001). Multivariate logistic regression analysis also showed that the treatment modality and the presence of hydrocephalus were independent risk factors for DCI.

CONCLUSION

DCI was less frequently observed in the coiling group, and clinical outcomes were also superior in the coiling group, especially for patients with severe SAH. The results showed a significant correlation between DCI and hydrocephalus.

摘要

目的

本研究旨在阐明蛛网膜下腔出血(SAH)后迟发性脑缺血(DCI)的临床预测因素。

方法

对 102 例破裂脑动脉瘤患者进行治疗(夹闭 77 例,血管内介入栓塞 25 例)。其中男 40 例,女 62 例。中位年龄为 59 岁(范围 31-88 岁)。采用改良 Rankin 量表评估治疗后 3 个月或出院时的功能结局。采用 χ(2)检验评估潜在临床危险因素与 SAH 后 DCI 的关系。

结果

52 例(51.0%)患者预后良好,13 例(12.7%)患者尽管治疗仍死亡。26 例患者出现 DCI,37 例患者出现脑积水。治疗组间临床结局存在差异(p=0.053),主要是因为在严重 SAH 患者中,血管内介入栓塞组的功能结局明显优于夹闭组(p=0.04)。血管内介入栓塞组 DCI 的发生率明显低于夹闭组(4.0%比 32.4%,p=0.001)。脑积水的存在与 DCI 的发生显著相关(p<0.001)。多变量 logistic 回归分析也显示,治疗方式和脑积水的存在是 DCI 的独立危险因素。

结论

血管内介入栓塞组 DCI 的发生率较低,血管内介入栓塞组的临床结局也较好,尤其是在严重 SAH 患者中。结果表明 DCI 与脑积水之间存在显著相关性。

相似文献

1
Clinical predictors of delayed cerebral ischemia after subarachnoid hemorrhage: first experience with coil embolization in the management of ruptured cerebral aneurysms.蛛网膜下腔出血后迟发性脑缺血的临床预测因素:在破裂脑动脉瘤的治疗中使用线圈栓塞的初步经验。
J Neurointerv Surg. 2011 Dec 1;3(4):344-7. doi: 10.1136/jnis.2010.004077. Epub 2011 Mar 1.
2
Aneurysm location and clipping versus coiling for development of secondary normal-pressure hydrocephalus after aneurysmal subarachnoid hemorrhage: Japanese Stroke DataBank.动脉瘤性蛛网膜下腔出血后继发性正常压力脑积水的发生与动脉瘤位置及夹闭术与栓塞术的关系:日本卒中数据库
J Neurosurg. 2015 Dec;123(6):1555-61. doi: 10.3171/2015.1.JNS142761. Epub 2015 Jul 31.
3
Endovascular embolization vs surgical clipping in treatment of cerebral aneurysms: morbidity and mortality with short-term outcome.血管内栓塞术与外科夹闭术治疗脑动脉瘤的比较:发病率、死亡率及短期预后
Surg Neurol. 2006 Sep;66(3):277-84; discussion 284. doi: 10.1016/j.surneu.2005.12.031.
4
Wide-necked intracranial aneurysms: treatment with stent-assisted coil embolization during acute (<72 hours) subarachnoid hemorrhage--experience in 61 consecutive patients.宽颈颅内动脉瘤:急性(<72小时)蛛网膜下腔出血期间的支架辅助弹簧圈栓塞治疗——61例连续患者的经验
Radiology. 2009 Oct;253(1):199-208. doi: 10.1148/radiol.2531081923. Epub 2009 Aug 25.
5
Ultra-early endovascular embolization of ruptured cerebral aneurysm and the increased risk of hematoma growth unrelated to aneurysmal rebleeding.超早期破裂脑动脉瘤血管内栓塞治疗与血肿增大风险增加无关,与动脉瘤再出血无关。
J Neurosurg. 2013 May;118(5):1003-8. doi: 10.3171/2012.11.JNS12610. Epub 2012 Dec 14.
6
The Barrow Ruptured Aneurysm Trial: 6-year results.巴罗破裂动脉瘤试验:6年结果。
J Neurosurg. 2015 Sep;123(3):609-17. doi: 10.3171/2014.9.JNS141749. Epub 2015 Jun 26.
7
The Barrow Ruptured Aneurysm Trial.巴罗破裂动脉瘤试验。
J Neurosurg. 2012 Jan;116(1):135-44. doi: 10.3171/2011.8.JNS101767. Epub 2011 Nov 4.
8
Which treatment modality is more injurious to the brain in patients with subarachnoid hemorrhage? Degree of brain damage assessed by serum S100 protein after aneurysm clipping or coiling.哪种治疗方式对蛛网膜下腔出血患者的大脑损伤更大?通过夹闭或栓塞动脉瘤后血清 S100 蛋白评估脑损伤程度。
Cerebrovasc Dis. 2012;34(1):38-47. doi: 10.1159/000338786. Epub 2012 Jun 29.
9
Neurological outcomes following intraprocedural rerupture during coil embolization of ruptured intracranial aneurysms.颅内破裂动脉瘤弹簧圈栓塞术中出现术中再破裂后的神经功能转归
J Neurosurg. 2015 Jan;122(1):128-35. doi: 10.3171/2014.9.JNS14616.
10
The Barrow Ruptured Aneurysm Trial: 3-year results.巴罗破裂动脉瘤试验:3 年结果。
J Neurosurg. 2013 Jul;119(1):146-57. doi: 10.3171/2013.3.JNS12683. Epub 2013 Apr 26.

引用本文的文献

1
Sex-Related Differences in Mortality, Delayed Cerebral Ischemia, and Functional Outcomes in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis.动脉瘤性蛛网膜下腔出血患者死亡率、迟发性脑缺血及功能预后的性别差异:一项系统评价和荟萃分析
J Clin Med. 2024 May 9;13(10):2781. doi: 10.3390/jcm13102781.
2
Clipping versus coiling for aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis of prospective studies.夹闭术与血管内介入栓塞术治疗颅内动脉瘤性蛛网膜下腔出血的前瞻性研究的系统评价和荟萃分析。
Neurosurg Rev. 2022 Apr;45(2):1291-1302. doi: 10.1007/s10143-021-01704-0. Epub 2021 Dec 6.
3
Blood Pressure Management in Intracranial Hemorrhage: Current Challenges and Opportunities.
颅内出血的血压管理:当前挑战与机遇
Curr Treat Options Cardiovasc Med. 2016 Apr;18(4):22. doi: 10.1007/s11936-016-0444-z.